Dechra logo
Dechra Puts Antibiotic-free Otitis Treatment In The Spotlight At London Vet Show
Veterinary professionals invited to discover how DuOtic can support a targeted approach to canine otitis externa at stand R30
Dechra will put the latest innovation in canine ear health centre stage at this year's London Vet Show, giving veterinary professionals the opportunity to learn more about DuOtic® and the role an antibiotic-free approach can play in appropriate cases of canine otitis externa.
With 26-44 per cent of canine otitis externa cases associated with yeast alone,* Dechra is encouraging veterinary professionals to consider whether an antibiotic is necessary for every otitis case and to explore the options available for dogs where Malassezia is identified without a bacterial component.
DuOtic is the first antibiotic-free, long-acting steroid and antifungal combination for Malassezia-only canine otitis externa and its introduction provides veterinary practices with a targeted treatment option for suitable cases without the unnecessary use of antibiotics.
At London Vet Show, visitors to Dechra's stand R30 will be able to speak directly with members of its sales and technical services teams about incorporating DuOtic into their approach to ear health, including case selection, treatment and follow-up.
Callum Watkins, UK & Ireland Brand Manager at Dechra, said: “Otitis externa is something veterinary teams manage every day, but not every case is the same. Where yeast alone is involved, there is an opportunity to take a more targeted approach and avoid unnecessary antibiotic use.
“London Vet Show gives us a great opportunity to have those conversations face to face and give veterinary professionals the opportunity to come and speak to the team about DuOtic, how it can fit into their approach to otitis cases and the practical benefits it can offer both the practice and pet owner.”
The long-acting gel formulation helps increase contact time at the infection site, with treatment administered in practice. The second dose also provides another opportunity to examine the patient and engage with the owner, helping veterinary teams build what Dechra describes as a ‘Lifelong Ear Partnership’.
This approach reflects Dechra's wider focus on supporting veterinary teams in canine ear health following a survey conducted in December 2025, which saw UK veterinarians identifying Dechra as the main brand they associate with otitis externa.**
Visitors will also have access to Dechra's technical services team, which has been recognised as the UK's number one pharmaceutical technical support line.*** The team will be on hand throughout the show to discuss canine otitis cases and provide practical support to veterinary professionals.
Alongside conversations with the team, visitors to stand R30 can take part in a spin-to-win game and experience Dechra's new cytology VR headset game.
Dechra will also host a CPD session at London Vet Show with Dan White MSc BSc RVN VTS/VNS (Dermatology), Nurse Specialist in Dermatology at Bristol Vet Specialists, titled ‘From consultation to resolution: How RVNs transform otitis outcomes’. The session will explore the role RVNs can play throughout an otitis case and the contribution of the veterinary nursing team to effective management. This session will take place at 11.20am to 12.10pm on Thursday 19 November in Gallery Suite 13.
Veterinary professionals interested in finding out more about DuOtic, accessing practice support or discussing ordering can visit Dechra on stand R30 during London Vet Show or contact their local Dechra territory sales manager by visiting here.
More from Dechra
1 week ago
255 views

2 days ago